ZOGENIX INTERNATIONAL LIMITED
Get an alert when ZOGENIX INTERNATIONAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
-£261m
USD -351,571,551
+7% highest in 3 filed years
Employees
—
Average over period
Profit before tax
£12m
USD 16,579,069
+596.4% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
-
Negative shareholders' funds
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £95,888,111 | £52,190,088 | £87,026,229 | +66.7% | |
| Operating profit | -£3,337,860 | £25,214,733 | £33,558,271 | +33.1% | |
| Profit before tax | -£3,258,815 | £1,769,245 | £12,321,865 | +596.4% | |
| Net profit | -£3,402,520 | -£12,236,878 | £19,594,233 | +260.1% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £62,342,716 | -£24,478,329 | -£4,884,096 | +80% | |
| Net assets | -£268,651,708 | -£280,888,586 | -£261,294,352 | +7% | |
| Equity | — | — | — | — | |
| Average employees | — | — | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | £0 | £0 | — | — |
Figures converted to GBP from USD at 0.743 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -3.5% | 48.3% | 38.6% | |
| Net margin | -3.5% | -23.4% | 22.5% | |
| Return on capital employed | -5.4% | — | — | |
| Gearing (liabilities / total assets) | 944.5% | 797.6% | 443.6% | |
| Current ratio | 22.21x | 0.62x | 0.94x | |
| Interest cover | -42.23x | 0.99x | 1.58x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- ZOGENIX INTERNATIONAL LIMITED 2015-11-17 → present
- BRABANT PHARMA LIMITED 2012-12-13 → 2015-11-17
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Zome Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company's Directors have assessed that there are no material uncertainties that may cast significant doubt on the ability of the Company to continue as a going concern.”
Group structure
- ZOGENIX INTERNATIONAL LIMITED · parent
- Zogenix ROI Limited 100%
Significant events
- “On 12th January 2026, the Company was transferred from its previous parent undertaking, Zogenix Europe Ltd, to another entity within the same group, UCB Biosciences Inc, as part of a wider internal reorganisation.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KHATRI, Yogesh | Director | 2022-04-29 | Oct 1965 | British |
| REYNDERS, Nico Victor | Director | 2024-12-01 | Aug 1972 | Belgian |
| SHAH, Viral Rohit | Director | 2022-04-29 | May 1985 | British |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BREW, Emma Rose | Secretary | 2022-01-01 | 2023-02-03 |
| RADIUS COMMERCIAL SERVICES LIMITED | Corporate Secretary | 2015-07-01 | 2018-04-24 |
| BARKER, Gavin Andrew, Dr | Director | 2015-12-01 | 2022-06-30 |
| CLARKE, Anthony, Dr | Director | 2013-01-15 | 2014-10-24 |
| DARCIS, Thierry Jean Philippe | Director | 2015-09-22 | 2017-11-22 |
| FARFEL, Gail, Dr | Director | 2015-12-01 | 2022-06-30 |
| FARR, Stephen James, Dr | Director | 2014-10-24 | 2021-06-28 |
| GALER, Bradley Stuart | Director | 2016-09-15 | 2022-04-29 |
| HAWLEY, Roger | Director | 2014-10-24 | 2015-08-11 |
| MCNAUGHT, Daniel James | Director | 2021-06-28 | 2022-08-19 |
| MISTRY, Arun Govindbhai | Director | 2015-12-01 | 2019-08-30 |
| PEYTON, Duncan Joseph | Director | 2012-12-13 | 2014-10-24 |
| RHOADS, Ann | Director | 2014-10-24 | 2017-03-13 |
| SAGROLIKAR, Ashish Manohar | Director | 2021-06-28 | 2022-04-29 |
| SMITH, Michael Patrick | Director | 2017-03-22 | 2022-03-18 |
| STEVENSON, Alexander James | Director | 2013-03-08 | 2014-10-24 |
| STEWART, Richard | Director | 2013-01-15 | 2014-10-24 |
| WAERNER, Lars Uno Torbjorn | Director | 2021-06-28 | 2022-06-30 |
| WILLIAMS, Alexander David Robert | Director | 2016-09-15 | 2018-05-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ucb Biosciences Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2026-01-12 | Active |
| Zogenix Europe Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2026-01-12 |
Filing timeline
Last 20 of 105 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-24 | AA | accounts | Accounts with accounts type full | |
| 2026-05-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-13 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-01-13 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-09-25 | AA | accounts | Accounts with accounts type full | |
| 2025-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-01-31 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-01-31 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-12-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-03 | AA | accounts | Accounts with accounts type full | |
| 2024-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-02 | AA | accounts | Accounts with accounts type full | |
| 2023-05-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-03 | AA | accounts | Accounts with accounts type full | |
| 2023-02-06 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-09-20 | TM01 | officers | Termination director company with name termination date | |
| 2022-07-11 | TM01 | officers | Termination director company with name termination date | |
| 2022-07-11 | TM01 | officers | Termination director company with name termination date | |
| 2022-07-11 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.